Toxic epidermal necrolysis in a melanoma patient under targeted therapy with encorafenib and binimetinib

J Dtsch Dermatol Ges. 2020 Oct;18(10):1159-1161. doi: 10.1111/ddg.14181. Epub 2020 Aug 9.
No abstract available

Publication types

  • Letter

MeSH terms

  • Benzimidazoles
  • Carbamates
  • Humans
  • Melanoma* / drug therapy
  • Stevens-Johnson Syndrome* / diagnosis
  • Stevens-Johnson Syndrome* / etiology
  • Sulfonamides

Substances

  • Benzimidazoles
  • Carbamates
  • Sulfonamides
  • binimetinib
  • encorafenib